Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Submitted by
admin
on July 15, 2011 - 1:01am
Source:
Seeking Alpha
News Tags:
Bristol-Myers Squibb
Dapagliflozin
FDA
advisory panels
diabetes
Headline:
Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Do Not Allow Advertisers to Use My Personal information
